Drew Burdon

Phagenesis Secures $42M Investment Led by EQT Life Sciences to Revolutionize Swallowing Disorder Treatment

(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series…

2 months ago

EQT Life Sciences and Gimv Lead €30M Series C Round for Onera Health to Advance Sleep Diagnostics

(IN BRIEF) Onera Health, a leader in sleep diagnostic and monitoring solutions, has successfully completed a €30 million ($32 million)…

4 months ago